BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37979367)

  • 21. Bioanalytical liquid chromatography-tandem mass spectrometric assay for the quantification of the ALK inhibitors alectinib, brigatinib and lorlatinib in plasma and mouse tissue homogenates.
    Sparidans RW; Li W; Schinkel AH; Schellens JHM; Beijnen JH
    J Pharm Biomed Anal; 2018 Nov; 161():136-143. PubMed ID: 30149189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitation of navtemadlin in human plasma and brain tissue by liquid chromatography-tandem mass spectrometry.
    Kagan AB; Anders NM; Hemingway A; Lee EQ; Kelly KR; Lee HC; Xu-Welliver M; Piekarz R; Rudek MA
    Biomed Chromatogr; 2022 Nov; 36(11):e5467. PubMed ID: 35895384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous determination of a novel c-Met/AXL dual-target small-molecule inhibitor BPI-9016M and its metabolites in human plasma by liquid chromatography-tandem mass spectrometry: Application in a pharmacokinetic study in Chinese advanced solid tumor patients.
    Cui X; Zheng X; Jiang J; Tan F; Ding L; Hu P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Nov; 1068-1069():33-40. PubMed ID: 29028616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracranial Efficacy of Adagrasib in Patients From the KRYSTAL-1 Trial With
    Negrao MV; Spira AI; Heist RS; Jänne PA; Pacheco JM; Weiss J; Gadgeel SM; Velastegui K; Yang W; Der-Torossian H; Christensen JG; Sabari JK
    J Clin Oncol; 2023 Oct; 41(28):4472-4477. PubMed ID: 37327468
    [No Abstract]   [Full Text] [Related]  

  • 25. Development and validation of a sensitive LC-MS/MS method for determination of gefitinib and its major metabolites in human plasma and its application in non-small cell lung cancer patients.
    Guan S; Chen X; Wang F; Xin S; Feng W; Zhu X; Liu S; Zhuang W; Zhou S; Huang M; Wang X; Zhang L
    J Pharm Biomed Anal; 2019 Aug; 172():364-371. PubMed ID: 31096095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. KRAS-targeted therapy in the treatment of non-small cell lung cancer.
    Yun J; Nakagawa R; Tham K
    J Oncol Pharm Pract; 2023 Mar; 29(2):422-430. PubMed ID: 35938195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitation of osimertinib, alectinib and lorlatinib in human cerebrospinal fluid by UPLC-MS/MS.
    de Leeuw SP; de Bruijn P; Koolen SLW; Dingemans AC; Mathijssen RHJ; Veerman GDM
    J Pharm Biomed Anal; 2023 Feb; 225():115233. PubMed ID: 36638566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a simple high-performance liquid chromatography-ultraviolet method for sotorasib quantification in human plasma: Implications for therapeutic drug monitoring.
    Hikita E; Gando Y; Chubachi H; Shirota M; Kushiyama A; Yasu T
    Drug Discov Ther; 2023 Sep; 17(4):289-293. PubMed ID: 37599084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. UPLC-MS/MS Assay for Quantification of Wedelolactone and Demethylwedelolactone in Rat Plasma and the Application to a Preclinical Pharmacokinetic Study.
    Wang BE; Zhang LT; Yang SB; Xu ZL
    Comb Chem High Throughput Screen; 2022 Jun; 25(8):1271-1277. PubMed ID: 35708104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Determination of sixteen antibiotics and four
    Li ZH; Hu XJ; Lu YF; Xie LN; Zhu Y
    Se Pu; 2023 May; 41(5):397-408. PubMed ID: 37087605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous determination of dacomitinib and its major metabolite, O-desmethyl dacomitinib in human plasma by LC-MS/MS and its application to clinical testing in patients with non-small cell lung cancer.
    Feng X; Ding Y; Zhang P; Fu Q; Zhang L; Zheng H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Oct; 1182():122940. PubMed ID: 34564058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid determination of fenoldopam in human plasma by UPLC-MS/MS for pharmacokinetic analysis in patients.
    Wang X; Zheng Z; He G; Mai L; Zhou Z; Zhong S; Lin Q; Shan Z; Deng C; Yang M; Yu X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jan; 978-979():78-82. PubMed ID: 25531873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A validated UPLC-MS/MS method for determination of tebipenem in human plasma and its application to a pharmacokinetic study in healthy volunteers.
    Xue S; Qin Z; Ren G; Yang Z; Lu Y; Zhang Y; Li N; Chen X; Zhao D
    J Pharm Biomed Anal; 2019 Jun; 170():30-39. PubMed ID: 30903927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and validation of a UPLC-MS/MS method with a broad linear dynamic range for the quantification of morphine, morphine-3-glucuronide and morphine-6-glucuronide in mouse plasma and tissue homogenates.
    Heydari P; Martins MLF; Rosing H; Hillebrand MJX; Gebretensae A; Schinkel AH; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Mar; 1166():122403. PubMed ID: 33246879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous Determination of Bosentan, Glimepiride, HYBOS and M1 in Rat Plasma by UPLC-MS-MS and its Application to Pharmacokinetic Study.
    Chen M; Song W; Wang S; Chen Q; Pan P; Xu T; Hu G; Zheng Z
    J Chromatogr Sci; 2016 Aug; 54(7):1159-65. PubMed ID: 27240565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of an LC-MS/MS method for quantifying ASK120067, a novel mutant-selective inhibitor of the epidermal growth factor receptor (EGFR) as well as its main metabolite in human plasma and its application in a pharmacokinetic study.
    Cui X; Wang S; Gao H; Li B; Shi Y; Guo H; Song T; Zheng X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jan; 1162():122488. PubMed ID: 33360679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantification of cefaclor in human plasma using SIL-IS LC-ESI-MS/MS for pharmacokinetics study in healthy Chinese volunteers.
    Chen X; Liu G; Wang C; Liu R; Wang M; Huang Y; Shen J; Jia Y
    Biomed Chromatogr; 2023 Aug; 37(8):e5638. PubMed ID: 37002731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of isoscoparin in mouse blood using UPLC-MS/MS and its pharmacokinetics.
    Huang X; Jiang H; Liang Q; Ma Y; Wang X
    Biomed Chromatogr; 2022 Sep; 36(9):e5419. PubMed ID: 35638105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of an LC-MS/MS assay for rapid and simultaneous quantification of 21 kinase inhibitors in human plasma and serum for therapeutic drug monitoring.
    Al Shirity ZN; Westra N; Hateren KV; Munnink THO; Kosterink JGW; Mian P; Hooge MNL; Touw DJ; Gareb B
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Sep; 1229():123872. PubMed ID: 37716342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination of astragaloside III in rat plasma by liquid chromatography-tandem mass spectrometry and its application to a rat pharmacokinetic study.
    Zhai Y; Li P; Wang M; Gong M; Qiu F
    Biomed Chromatogr; 2016 Feb; 30(2):105-10. PubMed ID: 26031660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.